» Articles » PMID: 38114984

Analysis of Complement System and Its Related Factors in Alzheimer's Disease

Overview
Journal BMC Neurol
Publisher Biomed Central
Specialty Neurology
Date 2023 Dec 20
PMID 38114984
Authors
Affiliations
Soon will be listed here.
Abstract

Alzheimer's disease (AD) is a primary cause of dementia. The complement system is closely related to AD pathology and may be a potential target for the prevention and treatment of AD. In our study, we conducted a bioinformatics analysis to analyze the role of the complement system and its related factors in AD using Gene Expression Omnibus (GEO) data. We also conducted a functional analysis. Our study verified that 23 genes were closely related to differentially expressed complement system genes in diseases after intersecting the disease-related complement system module genes and differentially expressed genes. The STRING database was used to predict the interactions between the modular gene proteins of the differential complement system. A total of 21 gene proteins and 44 interaction pairs showed close interactions. We screened key genes and created a diagnostic model. The predictive effect of the model was constructed using GSE5281 and our study indicated that the predictive effect of the model was good. Our study also showed enriched negative regulation of Notch signaling, cytokine secretion involved in the immune response pathway, and cytokine secretion involved in immune response hormone-mediated apoptotic signaling pathway. We hope that our study provides a promising target to prevent and delay the onset, diagnosis, and treatment of AD.

Citing Articles

Therapeutic Targets in Innate Immunity to Tackle Alzheimer's Disease.

Serradas M, Ding Y, Martorell P, Kulinska I, Castro-Gomez S Cells. 2024; 13(17.

PMID: 39272998 PMC: 11394242. DOI: 10.3390/cells13171426.

References
1.
De Schepper S, Ge J, Crowley G, Ferreira L, Garceau D, Toomey C . Perivascular cells induce microglial phagocytic states and synaptic engulfment via SPP1 in mouse models of Alzheimer's disease. Nat Neurosci. 2023; 26(3):406-415. PMC: 9991912. DOI: 10.1038/s41593-023-01257-z. View

2.
Liu L, Liu X, Zhou J, Wu W, Li X . An improved graph Laplacian regularization method for identifying biomarkers of Alzheimer's disease. J Theor Biol. 2022; 543:111121. DOI: 10.1016/j.jtbi.2022.111121. View

3.
Brai E, Alina Raio N, Alberi L . Notch1 hallmarks fibrillary depositions in sporadic Alzheimer's disease. Acta Neuropathol Commun. 2016; 4(1):64. PMC: 4929714. DOI: 10.1186/s40478-016-0327-2. View

4.
Bellenguez C, Kucukali F, Jansen I, Kleineidam L, Moreno-Grau S, Amin N . New insights into the genetic etiology of Alzheimer's disease and related dementias. Nat Genet. 2022; 54(4):412-436. PMC: 9005347. DOI: 10.1038/s41588-022-01024-z. View

5.
Yuan M, Feng Y, Zhao M, Xu T, Li L, Guo K . Identification and verification of genes associated with hypoxia microenvironment in Alzheimer's disease. Sci Rep. 2023; 13(1):16252. PMC: 10533856. DOI: 10.1038/s41598-023-43595-9. View